Propofol Reformulation
Anesthesia
Pre-clinicalActive
Key Facts
About LipoSeuticals
LipoSeuticals is a private, pre-revenue biotech firm founded in 2005, developing novel reformulations of sterile injectable drugs. The company leverages a proprietary drug delivery platform based on sugar-lipid polymers to enhance product profiles in therapeutic areas like anesthesiology, with Propofol as a key example. It is targeting a substantial U.S. market opportunity estimated at $7 billion annually for its portfolio. The company's strategy involves advancing its pipeline through development and seeking partnerships to reach commercialization.
View full company profileTherapeutic Areas
Other Anesthesia Drugs
| Drug | Company | Phase |
|---|---|---|
| Propofol Injectable | Avecho Biotechnology | Preclinical |